Addex Therapeutics (ADXN) Revenue (2019 - 2025)
Addex Therapeutics (ADXN) posted Revenue of $310.29 for Q4 2025, down 99.16% sequentially from $37158.3 in Q3 2025, and down 81.97% YoY from $1721.4 in Q4 2024.
Addex Therapeutics (ADXN) Revenue (2019 - 2025) Analysis & Trends
Addex Therapeutics has reported Revenue for 7 years, with the latest figure at $310.29 in Q4 2025.
- Quarterly Revenue fell 81.97% year-over-year to $310.29 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $39190.0 (down 91.46% YoY) and the FY2025 annual result came in at $36150.1, down 92.13% from the prior year.
- Revenue eased to $310.29 in Q4 2025 per ADXN's latest filing, from $37158.3 in the prior quarter.
- Over five years, Revenue peaked at $3.4 million in Q4 2021 and troughed at $310.29 in Q4 2025.
- A 5-year average of $553010.1 and a median of $319268.8 in 2024 frame the typical range for Revenue.
- The sharpest annual moves came in 2021 and 2024: Revenue surged 2407.84% in 2021, then slumped 99.0% in 2024.
- Over 5 years, Revenue stood at $3.4 million in 2021, then plunged by 82.02% to $614955.3 in 2022, then tumbled by 71.87% to $172993.7 in 2023, then plunged by 99.0% to $1721.4 in 2024, then tumbled by 81.97% to $310.29 in 2025.
- According to Business Quant data, Revenue over the past three periods registered $310.29, $37158.3, and $1721.4 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Addex Therapeutics | 515.38 Mn | 515.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 310.29 |
| Sep 30, 2025 | 37,158.26 |
| Dec 31, 2024 | 1,721.41 |
| Sep 30, 2024 | 62,139.06 |
| Jun 30, 2024 | 127,472.56 |
| Mar 31, 2024 | 267,493.91 |
| Dec 31, 2023 | 172,993.67 |
| Sep 30, 2023 | 371,043.76 |
| Jun 30, 2023 | 701,645.97 |
| Mar 31, 2023 | 541,545.69 |
| Dec 31, 2022 | 614,955.32 |
| Sep 30, 2022 | 423,933.55 |
| Jun 30, 2022 | 190,375.18 |
| Mar 31, 2022 | 256,882.21 |
| Dec 31, 2021 | 3.42 Mn |
| Sep 30, 2021 | 742,788.23 |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | 933,760.50 |
| Dec 31, 2020 | 4.29 Mn |
| Sep 30, 2020 | 29,618.67 |